Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigating the Feasibility of Home Monitoring of Visual Function in Populations at High Risk of Developing Diabetic Retinopathy (DR) Using Novel Game-based Technology (OKKO Health)

NCT07386613 is registered in ClinicalTrials.gov with Queen's University, Belfast as lead sponsor.

NCT NCT07386613
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07386613 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigating the Feasibility of Home Monitoring of Visual Function in Populations at High Risk of Developing Diabetic Retinopathy (DR) Using Novel Game-based Technology (OKKO Health)
Lead sponsor
Queen's University, Belfast
Phase
Observational
Overall status
Completed
Start date
September 9, 2023
Completion date
July 20, 2024
Enrollment
55 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes (dm), diabetes (insulin-requiring, type 1 or type 2), diabetes complication, diabetes pregnancy, diabetic retinopathy (dr), dialysis patients, gestational diabetes mellitus in pregnancy